Pierre Fabre   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Paris France (1962)

Organization Overview

First Clinical Trial
2002
NCT00198432
First Marketed Drug
1994
vinorelbine (navelbine)
First NDA Approval
1994
vinorelbine (navelbine)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Centre de Recherche sur La Peau | Institut de Recherche Pierre Fabre | Laboratoires Pierre Fabre | Orfagen | ORFAGEN LABORATORIES (France) | PIERRE FABRE | Pierre Fabre BIOMETRIE | PIERRE FABRE DERMA | Pierre Fabre Dermatology | Pierre Fabre Dermo Cosmetique | Pierre Fabre Ibérica, S.A. | Pierre Fabre Laboratories | Pierre Fabre Medicament | Pierre Fabre Medicament (co-developer) | Pierre Fabre Pharma GmbH